ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "informatics"

  • Abstract Number: 1924 • ACR Convergence 2021

    Patient Clustering Based on Multimorbidity Patterns Predicts Healthcare Utilization and Mortality in Rheumatoid Arthritis Within Independent Real-World Datasets

    Bryant England1, Yangyuna Yang1, Punyasha Roul1, Christian Haas2, Harlan Sayles1, Fang Yu1, Brian Sauer3, Joshua Baker4, Kaleb Michaud1, Jeffrey Curtis5 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Nebraska Omaha, Omaha, NE, 3University of Utah, Salt Lake City, UT, 4University of Pennsylvania, Philadelphia, PA, 5Division of Clinical Immunology and Rheumatology, Department of Medicine, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Rheumatoid arthritis (RA) leads to substantial healthcare utilization and premature mortality. Prior work has demonstrated that the overlapping presence of comorbid chronic conditions, termed…
  • Abstract Number: 0147 • ACR Convergence 2021

    A Qualitative Analysis of Methotrexate Self-Injection Education Videos on YouTube: An Update

    Amy Semaka, Hillary Wilson and Steven Katz, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Patients are turning to the Internet for guidance and information at an increasing rate, requiring clinicians to be aware of the constantly changing resources…
  • Abstract Number: 0211 • ACR Convergence 2021

    Unsupervised Machine-learning Algorithms for the Identification of Clinical Phenotypes in the Osteoarthritis Initiative Database

    David Demanse1, László B. Tankó2, Patrick Lustenberger3, Philipp Nikolaus3, Ilja Rasin3, Damian F. Brennan3, Franziska Saxer2, Ronenn Roubenoff4, Sumehra Premji1, Philip Conaghan5 and Matthias Schieker4, 1Novartis Pharma AG, Basel, Switzerland, 2Novartis Institutes for Biomedical Research, Basel, Switzerland, 3IBM Switzerland AG, Zürich, Switzerland, 4Novartis Institutes for Biomedical Research, Basel, Switzerland, Basel, Switzerland, 5Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom

    Background/Purpose: Osteoarthritis (OA) is a chronic disabling disease, for which there are only limited treatment options. One major challenge in the development of effective treatment…
  • Abstract Number: 0373 • ACR Convergence 2021

    Self-monitoring of Disease Activity with a Smartphone App Is Feasible in Routine Clinical Management of Patients with Axial Spondyloarthritis – a Proof of Concept Study

    Uta Kiltz1, Robin Kempin1, Jutta Richter2, Anna Schlegel1, Xenofon Baraliakos1, Styliani Tsiami1, Bjoern Buehring1, David Kiefer3 and Juergen Braun1, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany, 2Rheumatology and Hiller Research Unit, Heinrich-Heine-University Duesseldorf, Medical Faculty, Duesseldorf, Germany, 3Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Essen, Germany

    Background/Purpose: Assessment and monitoring of disease activity and functioning is of major importance for qualified management of patients with axial spondyloarthritis (axSpA). This includes tight…
  • Abstract Number: 0442 • ACR Convergence 2021

    Identification of Plexin D1 on Circulating Extracellular Vesicles as a Potential Biomarker of Polymyositis and Dermatomyositis

    Kenichi Uto1, Koji Ueda2, Takaichi Okano1, Kengo Akashi1, Soshi Takahashi3, Yuji Nakamachi4, Takamitsu Imanishi1, Seiji Kawano1, Yoshihiko Yano5 and Jun Saegusa6, 1Kobe University Hospital, Kobe, Japan, 2Japanese Foundation for Cancer Research, Tokyo, Japan, 3Shinko Hospital, Kobe, Japan, 4Kobe University School of Medicine, Kobe, Japan, 5Department of Clinical Laboratory, Kobe University Hospital, Kobe, Japan, 6Rheumatology and Clinical Immunology, Kobe University Hospital, Kobe, Japan

    Background/Purpose: Extracellular vesicles (EVs), including exosomes and microvesicles, are small membrane vesicles released by almost all cell types and are found circulating in blood and…
  • Abstract Number: 0561 • ACR Convergence 2021

    Enhancing the Identification of Rheumatoid Arthritis-Associated Interstitial Lung Disease in Electronic Health Records Through Text Mining of Computerized Tomography Reports

    Brent Luedders1, Brendan Cope2, Matt Devries2, W. Scott Campbell2, James Campbell2, Ted Mikuls3, Jeffrey Curtis4, Daniel Hershberger3 and Bryant England3, 1University of Nebraska Medical Center, Omaha, NE, United Kingdom, 2University of Nebraska Medical Center, Omaha, 3University of Nebraska Medical Center, Omaha, NE, 4Division of Clinical Immunology and Rheumatology, Department of Medicine, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Interstitial lung disease (ILD) is an extraarticular manifestation of RA that leads to increased morbidity and mortality. Algorithms incorporating multiple diagnostic and procedure codes…
  • Abstract Number: 0566 • ACR Convergence 2021

    Natural Language Processing of Electronic Health Record Notes Captures Forced Vital Capacity in Rheumatoid Arthritis-Associated Interstitial Lung Disease

    Punyasha Roul1, Yangyuna Yang1, Daniel Hershberger1, Ted Mikuls1, Jorge Rojas2, Jeffrey Curtis3, Joshua Baker4, Brian Sauer5 and Bryant England1, 1University of Nebraska Medical Center, Omaha, NE, 2VA Puget Sound, Seattle, WA, 3Division of Clinical Immunology and Rheumatology, Department of Medicine, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, 4University of Pennsylvania, Philadelphia, PA, 5University of Utah, Salt Lake City, UT

    Background/Purpose: Rheumatoid arthritis-interstitial lung disease (RA-ILD) has a poor long-term prognosis, including premature mortality. Longitudinal monitoring of patients in clinical and clinical trial settings includes…
  • Abstract Number: 0676 • ACR Convergence 2021

    Development, Refinement, and Validation of an Emergency Department Gout Flare Electronic Medical Record Alert

    Lesley Jackson1, Narender Annapureddy2, Kenneth Saag1, James Booth3, Giovanna Rosas1, Jeffrey Foster1, Amy Mudano1, Dongmei Sun4, John Osborne1, Tim Bongartz5, Erik Hess5, Colleen Lawrence6, Leah Dunkel6 and Maria I. Danila1, 1University of Alabama at Birmingham, Birmingham, AL, 2Vanderbilt University Medical Center, Nashville, TN, 3Department of Emergency Medicine, University of Alabama School of Medicine, Birmingham, AL, 4Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, AL, 5Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, 6Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Patients with acute gout are frequently treated in emergency departments (ED) and represent a typically underserved and understudied population. A key limitation of conducting…
  • Abstract Number: 0982 • ACR Convergence 2021

    B Cells Repertoire Repartition Predicts Response to Methotrexate at 6 and 12 Months in Naïve RA: A Machine Learning Driven Approach

    Aurelie Najm1, Shrutii Sarda2, Michelle Toro3, Loni Pickle3, Stephanie Ostresh3, Fraser Morton4, Geoffrey Lowman3, Andrew Felton5 and Carl Goodyear4, 1Institute of Infection, Immunity and Inflammation, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom, 2Clinical Sequencing Division, Specialty Diagnostics Group, Thermo Fisher Scientific, South San Francisco-CA, United States, San Francisco, 3Clinical Sequencing Division, Specialty Diagnostics Group, Thermo Fisher Scientific, Carlsbad, CA, 4University of Glasgow, Glasgow, United Kingdom, 5VP, Platforms, Research & Applied, Specialty Diagnostics Group, South San Francisco, CA

    Background/Purpose: The adaptive immune system plays a central role in Rheumatoid Arthritis (RA) pathogenesis. Moreover, the composition of the B cell repertoire and its perturbation…
  • Abstract Number: 0578 • ACR Convergence 2020

    Going Digital Due to COVID 19 Crisis: A Rapid Reorganisation of Medication Clinics

    Rian Penford1, Angela Reith1, Elaine Wren1 and Kirsten Mackay1, 1Torbay and South Devon NHS Foundation Trust, Torquay, United Kingdom

    Background/Purpose: Until the COVID 19 crisis we initiated DMARD(s) and Biologic therapies using shared medical clinics. More than 30 patients could seen per week, with…
  • Abstract Number: 0589 • ACR Convergence 2020

    The Ideal Mhealth Application for Rheumatoid Arthritis: Qualitative Findings from Stakeholder Focus Groups

    Diederik De Cock1, Maryline Vandeputte2, Rani Van Melder2, Michael Doumen2, Delphine Bertrand1, Veerle Stouten1, Sofia Pazmino1, Rene Westhovens3 and Patrick Verschueren4, 1KU Leuven, Leuven, Belgium, 2KU Leuven, Leuven, 3University Hospitals Leuven, Belgium, Leuven, Belgium, 4University Hospital Leuven, Leuven, Belgium

    Background/Purpose: Early access to specialized rheumatological care is under increasing pressure. Many countries are currently confronted with a relative shortage of practicing rheumatologists, while recent…
  • Abstract Number: 0973 • ACR Convergence 2020

    Novel Network Tool Highlights Key Features Associated with Disease Pathotypes and Response to Treatment in Early Rheumatoid Arthritis

    Elisabetta Sciacca1, Anna Surace2, Myles Lewis1, Salvatore Alaimo3, Vito Latora4, Felice Rivellese1, Alfredo Pulvirenti3, Alfredo Ferro3 and Costantino Pitzalis5, 1Centre for Experimental Medicine and Rheumatology, Queen Mary University of London, London, United Kingdom, 2Centre for Experimental Medicine and Rheumatology, Queen Mary University of London, Liverpool, United Kingdom, 3Bioinformatics Unit, Dept of Clinical and Experimental Medicine, University of Catania, Catania, Sicilia, Italy, 4School of Mathematical Sciences Queen Mary, University of London, London, United Kingdom, 5Queen Mary University of London, London, United Kingdom

    Background/Purpose: Biomedical research uses many statistical/bioinformatics tools to find genes or proteins differentially expressed between patient group of interest. However, biological elements are related to…
  • Abstract Number: 1302 • ACR Convergence 2020

    Exploration of Machine Learning Methods in Predicting Systemic Lupus Erythematosus Hospitalizations

    April Jorge1, Zhiyao Wu2, Tashrif Chowdhury2 and Yijun Zhao2, 1Massachusetts General Hospital, Boston, MA, 2Fordham University, Computer and Information Sciences Department, New York, NY

    Background/Purpose: Systemic lupus erythematosus (SLE) is a heterogeneous disease associated with increased morbidity and mortality, and severe SLE flares can lead to hospitalizations. Our objective…
  • Abstract Number: 1545 • ACR Convergence 2020

    An Artificial Intelligence (AI) Assistant Identifying Spinal Diffuse Idiopathic Skeletal Hyperostosis on Plain X-rays: A Pilot Deep Learning Study

    Sarah Ringsted1, Nishad Sathe1, Atul Deodhar2 and Dongseok Choi2, 1Oregon Health and Science University, Portland, OR, 2Oregon Health & Science University, Portland, OR

    Background/Purpose: Diffuse idiopathic skeletal hyperostosis (DISH) is a non-inflammatory condition most classically seen in the spine, and is characterized by ossification of the spinal ligaments…
  • Abstract Number: 1597 • ACR Convergence 2020

    Use of a Clinical Dashboard Improves the Documentation of Disease Severity Scores and May Facilitate the Implementation of Treat to Target Therapy

    Taylor Nelson1, Gary Kunkel2 and Grant Cannon2, 1University of Utah, Salt Lake City, 2Salt Lake City VA Medical Center and University of Utah, Salt Lake City

    Background/Purpose: Rheumatoid Arthritis (RA) management guidelines recommend the collection of Disease Activity Measures (DAMs) to direct therapy as a component of a “treat-to-target” (T2T) strategy. …
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology